ImmunSys, Inc.
6Patents
6Active
6Granted
46Portfolio score
Filing activity: Dec 5, 2014 → Nov 23, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10849678B2 | Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) | Human Necessities | 8 | Active |
| US11141216B2 | Radio-frequency electrical membrane breakdown for the treatment of high risk and recurrent prostate cancer, unresectable pancreatic cancer, tumors of the breast, melanoma or other skin malignancies, sarcoma, soft tissue tumors, ductal carcinoma, neoplasia, and intra and extra luminal abnormal tissue | Human Necessities | 4 | Active |
| US11497544B2 | Immunologic treatment of cancer | Human Necessities | 1 | Active |
| US11696797B2 | Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) | Human Necessities | 1 | Active |
| US11612426B2 | Immunologic treatment of cancer | Human Necessities | 0 | Active |
| US12295640B2 | Cancer immunotherapy by radiofrequency electrical membrane breakdown (RF-EMB) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.